Lisata Therapeutics, Inc. Share Price & Technical Analysis
LSTA · $3.14 (0.00%)
Healthcare / Biotechnology
$3.14
0.00%
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal can…
Price chart
Seasonality
May has 3 positive and 0 negative years (last 5 years shown)
0% return in May, 13% avg return in past 3 year May month.
112% return in 2026, 10% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 142% | -11% | 19% | -38% | 0% | – | – | – | – | – | – | – | 112% |
| 25 | -19% | -4% | 5% | 9% | 8% | 4% | -14% | -8% | 13% | 12% | -25% | -5% | -25% |
| 24 | -7% | 16% | 7% | -13% | 4% | 13% | -9% | -12% | 7% | -3% | 0% | 7% | 9% |
| 23 | 44% | -6% | 3% | 0% | 28% | -10% | -11% | -31% | -5% | 5% | 0% | 29% | 46% |
| 22 | -8% | -9% | 3% | -31% | 0% | 5% | -5% | -3% | -40% | -9% | -17% | -31% | -144% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$29.60M
P/E ratio
—
52W high
$5.07
52W low
$1.81
Volume
1,961
Beta
0.81
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Lisata Therapeutics, Inc. share price today?
- Lisata Therapeutics, Inc. (LSTA) last traded around $3.14 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does LSTA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for LSTA. Download the app for real-time alerts.
- How can I analyze Lisata Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.